Modipafant
- Generic Name
- Modipafant
- Drug Type
- Small Molecule
- Chemical Formula
- C34H29ClN6O3
- CAS Number
- 122957-06-6
- Unique Ingredient Identifier
- 1DMI0E5023
- Background
Modipafant is under investigation in clinical trial NCT02569827 (Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore).
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
Phase 1
Withdrawn
- Conditions
- Dengue Fever
- Interventions
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Singapore General Hospital
- Registration Number
- NCT02569827
- Locations
- 🇸🇬
Singhealth Investigational Medicine Unit, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath